A new publication concerning insulin glargine appeared on September 25, 2026. Titled "Authors Respond: Insulin Glargine Utilization and Spending Before and After the First Biosimilar Insulin Glargine: A Real-World Data Study," it was published in the Journal of General Internal Medicine.
This entry represents an authors' response related to the original real-world data study on insulin glargine utilization and spending patterns. The publication is indexed under PubMed ID 42791446.
No findings, conclusions, or data points from this response are detailed here beyond its title and publication venue. The piece is part of ongoing academic discussion in the journal regarding the original study's methodology or conclusions, though the specific content of that discussion is not provided in this record.
Readers interested in the broader context of biosimilar insulin glargine research and prior findings on this topic may wish to consult the original study referenced in this authors' response, as well as the journal listing for related correspondence.
For more background on this compound, see the insulin glargine overview.